Trial NCT01282333

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2011-02576
Secondary IDs: CDR0000693751 PCI-10-037 U01CA099168 UPCI 10-037

Last trial update was posted on 2013-07-02

MeSH Interventions

Gemcitabine Veliparib

MeSH Conditions

Bile Duct Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Transitional Cell Gallbladder Neoplasms Kidney Neoplasms Liver Neoplasms Lung Neoplasms Pancreatic Neoplasms Ureteral Neoplasms Urinary Bladder Neoplasms

Other Conditions

Advanced Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter Regional Transitional Cell Cancer of the Renal Pelvis and Ureter Stage III Bladder Cancer Stage III Pancreatic Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Bladder Cancer Stage IV Non-small Cell Lung Cancer Stage IV Pancreatic Cancer Transitional Cell Carcinoma of the Bladder Unresectable Extrahepatic Bile Duct Cancer Unresectable Gallbladder Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID